Core Viewpoint - Company has received a medical device registration certificate for its Digoxin assay kit, which is expected to enhance its product line in the in vitro diagnostic sector and improve its market competitiveness [1] Group 1 - The product name is Digoxin Assay Kit (Magnetic Particle Chemiluminescent Immunoassay) [1] - The kit is designed for the quantitative measurement of Digoxin levels in human serum or plasma [1] - The registration certificate number is 京械注准20252400878 [1] Group 2 - The acquisition of the medical device registration certificate enriches the company's product offerings in the field of in vitro diagnostics [1] - This development is anticipated to positively impact the company's core competitiveness and market expansion capabilities [1] - The company expects this to have a favorable effect on its future operations [1]

Core Viewpoint - Jiukang Bio (300406) has received a medical device registration certificate for its digoxin assay kit from the Beijing Drug Administration, indicating a significant regulatory approval for the company’s product in the healthcare market [1] Company Summary - The digoxin assay kit is designed for the quantitative measurement of digoxin levels in human serum or plasma, which highlights the company's focus on developing diagnostic tools for critical health monitoring [1] Industry Summary - The approval of the digoxin assay kit reflects the growing demand for reliable diagnostic solutions in the healthcare industry, particularly in the area of cardiac health management [1]